Monsanto Roundup Lawsuit

Friday, May 21, 2010

EMAIL TO GLAXOSMITHKLINE RE; PAXIL STUDY IN CHILDREN


Image: artofthestate.co.uk



Dear GSK,

I am writing to you as I am confused regarding an ongoing Paxil [Seroxat] study currently underway from GlaxoSmithKline, Japan.

I refer you to The Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) - http://clinicaltrials.gov/ct2/show/NCT00812812

As a matter of public record I would like either GlaxoSmithKline UK or GlaxoSmithKline Japan to explain why this study has been put in place. In other words, what is GlaxoSmithKline's motive behind this study?

I am bewildered why GlaxoSmithKline would wish to pursue testing the safety and efficacy of paroxetine in children when you have already deemed that paroxetine is not safe for children.

I strongly object to this clinical trial and I can see no beneficial reason why you are undertaking it. I also fear for those children taking part in the study.

I don't think I need to point you to the Paxil 329 studies, do I?

I am sure that you are aware who I am, your employees and lawyers representing you seem to spend an awful amount of time on my blog.

Regardless, of who I am and what I write about, I would like an answer in writing regarding your motives behind The Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

I have a genuine concern for the children taking part in this study and also question your motives behind such a program.

Sincerely,

Bob Fiddaman


Author of Seroxat Sufferers

Author of the book, The Evidence, However, Is Clear...The Seroxat Scandal


**Interested parties have been blind copied.

---

A reminder of what we are dealing with here.



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment